TOCQUEVILLE ASSET MANAGEMENT L.P.

Position in IMMX — Immix Biopharma, Inc.

CIK 883961 New York, NY

Position in IMMX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$912,950

+$97,150 QoQ

Shares Held

88,550

-1.1% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#46

of 108 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TOCQUEVILLE ASSET MANAGEMENT L.P. holds $29,586,127 across 12 Biotechnology names. IMMX ranks #7 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	251,215	$19,918,837
2	REGN	Regeneron Pharmaceuticals, Inc.	3,315	$2,067,035
3	CSBR	Champions Oncology, Inc.	295,658	$1,821,253
4	BBIO	BridgeBio Pharma, Inc.	19,650	$1,463,532
5	MGTX	MeiraGTx Holdings plc	77,700	$1,049,727
6	RARE	Ultragenyx Pharmaceutical Inc.	31,250	$1,043,437
7	IMMX	Immix Biopharma, Inc. This page	88,550	$912,950
8	AXSM	Axsome Therapeutics, Inc.	2,300	$562,971

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$912,950	88,550	-1.1%	Shares	Sole	2026-08-10
2026-03-31	$815,800	89,550	+30.6%	Shares	Sole	2026-05-12
2025-12-31	$358,516	68,550	+70.3%	Shares	Sole	2026-02-12
2025-09-30	$84,122	40,250	+37.4%	Shares	Sole	2025-11-13
2025-06-30	$60,651	29,300	0.0%	Shares	Sole	2025-08-12
2025-03-31	$49,224	29,300	-23.5%	Shares	Sole	2025-05-13
2024-12-31	$84,260	38,300	-11.5%	Shares	Sole	2025-02-10
2024-09-30	$64,517	43,300	+14.6%	Shares	Sole	2024-11-08
2024-06-30	$74,844	37,800	0.0%	Shares	Sole	2024-08-12
2024-03-31	$116,046	37,800	+89.0%	Shares	Sole	2024-05-09
2023-12-31	$138,400	20,000	+66.7%	Shares	Sole	2024-02-12
2023-09-30	$41,040	12,000	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.